Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
AHA Journals This Week | July 6, 2020
07/06/2020 | AHA Journals This Week July 6, 2020
JAHA | Featured Articles | June 2, 2020
06/02/2020 | New featured articles from JAHA for June 2, 2020
JAHA | Featured Articles | May 18, 2020
05/22/2020 | New featured articles from JAHA for May 18, 2020
Collaboration with LLNL shares COVID-19 research data
05/22/2020 | The American Heart Association is pleased to announced that our collaboration with Lawrence Livermore National Labs (LLNL) on the protein atlas developed through the AHA Center for Accelerated Discovery is being leveraged to help accelerate discovery of therapeutic antibodies or antiviral drugs for SARS-CoV-2, the virus that causes COVID-19.
AHA, ACC redefine guideline processes
04/27/2020 | In a historic move, the AHA and ACC re-visited their 30-year partnership of jointly producing clinical practice guidelines for the cardiovascular community.
JAHA | Featured Articles | March 2020
04/10/2020 | New featured articles from JAHA for March 2020
2020 AHA/ACC Key Data Elements and Definitions for Coronary Revascularization
03/23/2020 | Heart disease is the leading cause of death in the US; coronary artery disease is the most common type of heart disease.